12-51269266-G-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001031628.2(SMAGP):āc.13C>Gā(p.Leu5Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00025 in 1,613,956 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001031628.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMAGP | NM_001031628.2 | c.13C>G | p.Leu5Val | missense_variant | 2/4 | ENST00000603798.6 | NP_001026798.1 | |
SMAGP | NM_001033873.1 | c.13C>G | p.Leu5Val | missense_variant | 2/4 | NP_001029045.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMAGP | ENST00000603798.6 | c.13C>G | p.Leu5Val | missense_variant | 2/4 | 1 | NM_001031628.2 | ENSP00000475068.1 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152220Hom.: 1 Cov.: 31
GnomAD3 exomes AF: 0.000530 AC: 132AN: 249260Hom.: 0 AF XY: 0.000451 AC XY: 61AN XY: 135222
GnomAD4 exome AF: 0.000250 AC: 365AN: 1461618Hom.: 1 Cov.: 31 AF XY: 0.000245 AC XY: 178AN XY: 727104
GnomAD4 genome AF: 0.000256 AC: 39AN: 152338Hom.: 1 Cov.: 31 AF XY: 0.000242 AC XY: 18AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 23, 2023 | The c.13C>G (p.L5V) alteration is located in exon 2 (coding exon 1) of the SMAGP gene. This alteration results from a C to G substitution at nucleotide position 13, causing the leucine (L) at amino acid position 5 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at